About us

At a glance

Nestlé Skin Health is part of Nestlé's global business portfolio. To meet a broad range of skin health needs, we offer a range of leading medical and consumer skin health brands, through three business units: Prescription, Aesthetics (both under the Galderma brand), and Consumer care.

Key facts

7 innovation areas

We focus our innovation on 7 areas: acne, rosacea, psoriasis, atopic dermatitis, skin aging, sun protection and skin cancer.

7 manufacturing sites

In 2016, the 1,300+ employees at our 7 manufacturing sites produced 200 million units. We make 75% of our products in house.

World presence

We operate from 50 sites in 40 countries, with our headquarters in Lausanne, Switzerland.

Sales by region

North America 44%
International 56%


 

Sales by business

Consumer 35%
Aesthetics 34%
Prescription 31%

Creating shared value

We collaborate with the broad skin health community:

Leadership

Find out about our leadership team by clicking here.

A timeline of our history

1981
Foundation of Galderma

1984
Galderma discovers Adapalene

1986
First commercial operations

1995
Acne treatment Differin launch

2000
Opening of production site in Baie d’Urfé, Canada

2001
Licensing agreement for Metvix (Skin cancer)

2004
Opening of production site in Hortolândia, Brazil

2007
Launch of Differin 0.3%

2008
Launch of Epiduo

2009
Launch of Azzalure and Restylane Injector

 

 

2011
Acquisition of Q-med, maker of Restylane

2014
Nestlé Skin Health is founded

2016
Formation of The Proactiv Company

2018
Opening of production site in Taizhou, China